Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgolide Meglumine Injection Skin Allergy Test Study
CTR20140899Phase 4Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Ginkgo diterpene lactone meglumine in ischemic stroke, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jan 2015; status: completed.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20140899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140899.